All the offerings of our platform come into play, creating a programatic ecosystem where everything works in harmony to drive expedient and successful outcomes.
That’s why we developed Benuvia Specialized Solutions. Our suite of focused programs was designed to harness the full power of our Unified Services Platform to help you overcome challenges and achieve your goals with unmatched speed and precision. These programs are more than services—they’re a partnership in progress. With Benuvia, you gain the confidence of working with a trusted team committed to helping you deliver groundbreaking therapies faster and more effectively.
We accelerate discovery by streamlining the creation of high-quality active ingredients, reducing time from concept to synthesis. Our fast, efficient process keeps you ahead in an ever-evolving market.
Learn More
We simplify your path to trials, connecting development to clinical readiness. Integrating formulation, regulatory, and manufacturing expertise, reduces delays and fast tracks you to trials.
Learn More
We align development, manufacturing, and compliance to accelerate your path to patients. With seamless coordination, we help you avoid delays and meet market demands with confidence.
Learn More
We ensure your product meets rigorous quality standards throughout its lifecycle. Our tailored testing protocols safeguard against degradation, giving you confidence in every dose delivered.
Learn More
Specialized Solutions for every stage. Discovery Booster, Clinical Expressway, Market Accelerator, and Stability Solutions are designed to bring your breakthroughs to life with precision and speed. Visit our Knowledge Center to explore case studies, white papers, and success stories that highlight how we deliver innovation and efficiency tailored to your needs.
Dr. Reddy is an accomplished synthetic organic chemist with over 25 years of experience in the synthesis of complex molecules. Dr. Reddy came to Benuvia in August 2024 after working over 20 years as Principal Scientist at Merck KGaA. At Merck KGaA Dr. Reddy has made many significant contributions in the areas of Research and Development of new product and process development and in the implementation of new technologies. Dr. Reddy has two U.S. Patents and published fifteen papers and made several presentations to national conferences and professional groups. Dr. Reddy holds Bachelor of Science degree in Chemistry and a master’s degree in Organic Chemistry from the Osmania University, Hyderabad, and a Ph.D. in Synthetic Organic Chemistry from the National Chemical Laboratory, Pune, India. Dr. Reddy trained in the field of synthetic organic chemistry and medicinal chemistry as Postdoctoral Fellow at University of Texas Southwestern Medical Center at Dallas, Texas, and at State University of New York at Buffalo, New York.
"*" indicates required fields
